PACT updated with 3 new intentions for RMOA / 4 finalised RMOA

On 15 August 2017, ECHA’s Public Activities Coordination Tool (PACT) was updated with the following new intentions for Risk Management Option Analysis (RMOA):

  • Decamethylcyclopentasiloxane [fusion_builder_container hundred_percent=”yes” overflow=”visible”][fusion_builder_row][fusion_builder_column type=”1_1″ background_position=”left top” background_color=”” border_size=”” border_color=”” border_style=”solid” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”no” center_content=”no” min_height=”none”][CAS# 541-02-6]
  • Octamethylcyclotetrasiloxane [CAS# 556-67-2]
  • Perfluorobutanoic acid and its salts and precursors [CAS# 375-22-4]

In addition, the PACT was updated with the following finalised RMOA:

  • (1-methyl-1,2-ethanediyl)bis[oxy(methyl-2,1-ethanediyl)] diacrylate [CAS# 42978-66-5]
  • 2-ethylhexyl acrylate [CAS# 103-11-7]
  • Cobalt titanite green spinel [CAS# 68186-85-6]
  • Penta-1,3-diene [CAS# 504-60-9]

This update brought the number of PACT RMOA and hazard assessment substances to 377. ECHA’s website gives advanced notice on the substances being considered by authorities for regulatory risk management, together with the routes that are being considered, for example Harmonised Classification and Labelling (CLP), Authorisation or Restriction. The aim of the advance notice is to increase the predictability and transparency of the process by which substances are considered for regulatory risk management action. The PACT lists the substances for which a RMOA or an informal hazard assessment for PBT/vPvB (persistent, bioaccumulative and toxic/very persistent and very bioaccumulative) properties or endocrine disruptor properties is either under development or has been completed since the implementation of the SVHC Roadmap commenced in February 2013. RMOAs, hazard assessments and their conclusions are compiled on the basis of available information and may change in the light of new information or further assessment.

Chemtrac, 16 August 2017 ;[/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]